Clinical Trials Directory

Trials / Unknown

UnknownNCT02823054

One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
208 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Coronary artery bypass grafting is a current cardiac surgery. Internal thoracic artery is usually taking to restore coronary revascularization, and its dissection can lead to accidental or voluntary pleural effusions. Respiratory complications are frequent, due to the drainage required. In this study, the investigators propose one-lung ventilation to facilitate artery grafting and surgical procedure. The investigators will include all adult patients with elective coronary artery bypass surgery (CABG) by internal thoracic artery, in a prospective, controlled, randomized and monocentric study. The main objective is to demonstrate that one-lung ventilation using EZ-Blocker can reduce pleural effusion defined by presence of drainage and/or pneumothorax on X-ray chest in the ICU.

Conditions

Interventions

TypeNameDescription
DEVICEEZ-Blockerthe Blocker group, the EZ-Blocker will be set up after anesthesia induction and standard orotracheal intubation to allow lung exclusion during homolateral internal thoracic artery sampling, and thus a one-lung ventilation. This material will be removed at the end of surgical surgery.

Timeline

Start date
2017-01-04
Primary completion
2020-01-01
Completion
2020-01-01
First posted
2016-07-06
Last updated
2018-08-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02823054. Inclusion in this directory is not an endorsement.